Europe Cold Sore Treatment Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
 Período de previsão |
2021 –2028 |
 Tamanho do mercado (ano base ) | USD 176.72 Million |
 Tamanho do mercado ( Ano de previsão) | USD 273.12 Million |
 CAGR |
% |
| Principais participantes do mercado |
>Mercado Europeu de Tratamento da Afta, por Tipo de Estirpe (Vírus Herpes Simplex Tipo 1 e Vírus Herpes Simplex Tipo 2), Terapêutica (Agentes Antivirais, Agentes Analgésicos e Outros), Tipo de Medicamento (de Marca e Genérico), Tipo de Dosagem ( Oral, Tópico) e outros), utilizador final (hospitais, cuidados domiciliários, clínicas especializadas e outros), canal de distribuição (farmácia hospitalar, farmácia de retalho, farmácia online e outros), país (Alemanha, Reino Unido, França, Itália, Espanha, Rússia, Países Baixos, Suíça, Bélgica, Turquia e Resto da Europa) Tendências e previsões da indústria para 2028.
Análise de mercado e insights: mercado europeu de tratamento do herpes labial
Espera-se que o mercado de tratamento do herpes labial ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 5,9% no período de previsão de 2021 a 2028 e deverá atingir os 273,12 milhões de dólares até 2028, contra 176,72 milhões de dólares em 2021.
O aumento da prevalência do vírus Herpes simplex (HSV) a nível global e a proliferação nos modos de transmissão do HSV são os principais impulsionadores que impulsionaram a procura do mercado no período de previsão.
O herpes labial ou herpes oral são pequenas bolhas semelhantes a escoriações que ocorrem devido à infeção causada pelo vírus Herpes simplex (HSV). O herpes labial ocorre geralmente no rosto, em redor dos lábios, queixo, bochechas e narinas. Geralmente causam dor e comichão antes de rebentarem. O HSV é um dos vírus mais comuns que afeta a população global e é endémico em todo o mundo. Até 90% das pessoas em todo o mundo têm pelo menos uma forma de HSV.
O vírus Herpes Simplex (HSV) infeta geralmente a população pediátrica em todo o mundo, mas de acordo com a OMS, as pessoas com idades compreendidas entre os 30 e os 49 anos correm um maior risco de contrair o vírus, e a prevalência do HSV aumenta com a idade. O HSV tem dois tipos: HSV tipo 1 e HSV tipo 2. O HSV-1 causa herpes labial ou herpes oral em redor dos lábios, narinas e bochechas. Enquanto o HSV-2 causa herpes genital. O HSV pode ser transmitido através do modo de transmissão direta, que inclui contacto oral, induzindo infeção com herpes oral, da boca para superfícies cutâneas que parecem normais e quando não há sintomas presentes.
O relatório do mercado de tratamento do herpes labial fornece detalhes da quota de mercado, novos desenvolvimentos e análise do pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos , expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado contacte-nos para um Analyst Brief, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.
Âmbito do mercado europeu de tratamento do herpes labial e dimensão do mercado
O mercado de tratamento do herpes labial está categorizado em seis segmentos notáveis que se baseiam no tipo de estirpe, tipo terapêutico, tipo de medicamento, tipo de dosagem, utilizador final e canal de distribuição.
- Com base no tipo de estirpe, o mercado de tratamento do herpes labial está segmentado em vírus herpes simplex tipo 1 e vírus herpes simplex tipo 2. Em 2021, o segmento do vírus Herpes simplex tipo 1 (HSV) está a dominar o mercado devido ao seu rápido aumento de prevalência.
- Com base no tipo terapêutico, o mercado do tratamento do herpes labial está segmentado em agentes antivirais, agentes analgésicos, entre outros. Em 2021, espera-se que o segmento antiviral domine o mercado global de tratamento do herpes labial devido ao aumento da contagem de doenças infeciosas causadas pelo vírus herpes simplex e prevê-se que o pipeline melhorado de produtos em agentes antivirais domine o mercado.
- Com base no tipo de medicamento, o mercado de tratamento do herpes labial está segmentado em genéricos e de marca . Em 2021, os genéricos estão a dominar o mercado global de tratamento do herpes labial porque são muito mais baratos em comparação com os medicamentos de marca e devido à natureza económica e ao aumento da utilização para o tratamento do herpes labial em todo o mundo.
- Com base no tipo de dosagem, o mercado do tratamento do herpes labial está segmentado em oral , tópico , entre outros. Em 2021, prevê-se que o segmento oral domine o mercado global de tratamento do herpes labial devido à sua facilidade de absorção e flexibilidade para acomodar diversos tipos de medicamentos.
- Com base no utilizador final, o mercado de tratamento do herpes labial está segmentado em hospitais , cuidados domiciliários , clínicas especializadas, entre outros. Em 2021, o segmento de cuidados domiciliários domina o mercado pela facilidade no tratamento ao domicílio e pela fácil disponibilidade de medicamentos.
- Com base no canal de distribuição, o mercado de tratamento do herpes labial está segmentado em farmácia hospitalar, farmácia de retalho e farmácia online. Em 2021, prevê-se que a farmácia hospitalar domine o mercado devido ao aumento do acesso a medicamentos para o herpes labial e prevê-se que o aumento do número de prescrições diárias de medicamentos para o herpes labial domine o mercado.
Análise ao nível do país do mercado de tratamento do herpes labial
O mercado de tratamento do herpes labial está categorizado em seis segmentos notáveis que se baseiam no tipo de estirpe, tipo terapêutico, tipo de medicamento, tipo de dosagem, utilizador final e canal de distribuição.
Os países abrangidos no relatório de mercado do tratamento do herpes labial são a Alemanha, o Reino Unido, a França, a Itália, a Espanha, a Rússia, os Países Baixos, a Suíça, a Bélgica, a Turquia e o Resto da Europa.
Espera-se que a Alemanha na Europa cresça com a taxa de crescimento mais promissora no período de previsão de 2021 a 2028 devido ao aumento muito rápido devido ao rápido aumento da população de doentes e aos avanços na tecnologia. Espera-se que a França domine devido aos crescentes programas de sensibilização para as doenças sexualmente transmissíveis que atuam como impulsionadores do mercado de tratamento do herpes labial. No entanto, prevê-se que o Reino Unido domine devido ao aumento do rendimento disponível.
A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado nacional que impactam as tendências atuais e futuras do mercado. Dados como novas vendas, vendas de reposição, demografia do país, atos regulamentares e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, a presença e a disponibilidade das marcas europeias e os desafios enfrentados devido à concorrência grande ou escassa das marcas locais e nacionais, o impacto dos canais de vendas são considerados, ao mesmo tempo que fornecem uma análise de previsão dos dados do país.
As iniciativas estratégicas dos fabricantes estão a criar novas oportunidades para os participantes do mercado de tratamento do herpes labial
O mercado de tratamento do herpes labial também fornece análises de mercado detalhadas para o crescimento de cada país na indústria estética com vendas de tratamento do herpes labial, impacto do avanço no tratamento do herpes labial e mudanças nos cenários regulamentares com o seu apoio ao mercado de tratamento de herpes labial. Os dados estão disponíveis para o período histórico de 2010 a 2019.
Análise do cenário competitivo e da quota de mercado do tratamento do herpes labial
O panorama competitivo do mercado de tratamento do herpes labial fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produtos, aprovações de produtos, patentes, largura do produto e respiração, domínio da aplicação, curva da linha de vida da tecnologia. Os dados acima fornecidos estão apenas relacionados com o foco da empresa relacionado com o mercado de tratamento do herpes labial.
As principais empresas fornecedoras de estética GlaxoSmithKline plc, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc. (uma subsidiária da Zydus Cadila), Cipla Inc., AiCuris, Teva Pharmaceuticals USA, Inc. Ltd.), Aurobindo Pharma USA (uma subsidiária da Aurobindo Pharma), WOCKHARDT, Novartis AG, Hikma Pharmaceuticals PLC, Hetero Healthcare Limited, Apotex Inc., HRA Pharma, entre outros. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.
Muitos lançamentos e acordos de produtos são também iniciados por empresas de todo o mundo que também estão a acelerar o mercado do tratamento do herpes labial.
- Em maio de 2020, a Teva Pharmaceutical Industries Ltd. informou que a assembleia anual de acionistas de 2020 será realizada online, analisando o cenário da COVID-19 e no interesse da saúde e segurança dos seus acionistas, administradores, executivos e colaboradores. Isto ajudará na criação e discussão de estratégias para o próximo ano.
A colaboração, as joint ventures e outras estratégias do player de mercado estão a potenciar o mercado da empresa no mercado de tratamento do herpes labial, o que também oferece o benefício para a organização melhorar a sua oferta de tratamento do herpes labial.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of EUROPE Cold Sore Treatment MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- THERAPEUTICS LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- MARKET drug type COVERAGE GRID
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- Pipeline analysis
- Epidemiology
- market overview
- drivers
- Growing prevalence of cold sore infection
- Proliferation in modes of transmission of herpes simplex virus
- Increasing awareness about sexually transmitted diseases
- Availability of generic drugs
- Rising rate of HSV infection among women
- RESTRAINTS
- Patent termination of marketed drugs
- Risks of other diseases associated with cold sore
- Dearth of awareness about the onset and symptoms of cold sore treatment
- OPPORTUNITIES
- Increasing disposable income
- Strategic Initiatives by market players
- Increasing research and Development
- Increasing use of cold sore patches
- CHALLENGES
- Rise in alternative treatments
- Emergence of drugs resistant to acyclovir
- Side effects Associated with medications used for treating cold sore
- COVID-19 IMPACT ON EUROPE COLD SORE TREATMENT MARKET
- impact on price
- Impact on demand
- IMPACT ON SUPPLY CHAIN
- strategic decisions for manufacturers
- CONCLUSION
- Europe COLD SORE TREATMENT MARKET, BY strain TYPE
- overview
- HERPES SIMPLEX TYPE 1 VIRUS
- HERPES SIMPLEX TYPE 2 VIRUS
- Europe COLD SORE TREATMENT MARKET, BY therapeutics
- overview
- ANTIVIRAL AGENTS
- Acyclovir
- Famciclovir
- Penciclovir
- Valacyclovir
- Docosanol
- ANALGESIC AGENTS
- Carmex
- Herpecin
- others
- others
- Europe COLD SORETREATMENT MARKET, BY drug type
- overview
- generics
- otc
- branded
- prescription
- otc
- Europe COLD SORE TREATMENT MARKET, BY dosage type
- overview
- Oral
- Tablets
- Pills
- TOPICAL
- cream
- Ointments
- Gel
- spray
- others
- Europe COLD SORE TREATMENT MARKET, BY end user
- overview
- HOme care
- HOspitals
- SPECIALTY CLINICS
- OTHERS
- Europe COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL
- overview
- Hospitals Pharmacy
- online Pharmacy
- RETAIL Pharmacy
- EUROPE Cold sore treatment market, by Geography
- EUROPE
- germany
- france
- U.K.
- ITALY
- SPAIN
- RUSSIA
- SWITZERLAND
- NETHERLAND
- TURKEY
- IRELAND
- BELGIUM
- POLAND
- AUSTRIA
- NORWAY
- HUNGARY
- LITHUANIA
- REST OF EUROPE
- Europe Cold Sore Treatment Market: COMPANY landscape
- company share analysis: Europe
- SWOT
- company profile
- GLAXOSMITHKLINE PLC
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ORTHO DERMATOLOGICS’ (A DIVISION OF BAUSCH HEALTH COMPANIES INC.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- FOUNDATION CONSUMER HEALTHCARE
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- NOVARTIS AG
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- AMNEAL PHARMACEUTICALS LLC
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- AICURIS GMBH & CO. KG
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- APOTEX INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- AUROBINDO PHARMA USA (A SUBSIDIARY OF AUROBINDO PHARMA)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- CIPLA LIMITED
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- GLENMARK PHARMACEUTICALS, INC., USA (A SUBSIDIARY OF GLENMARK PHARMACEUTICAL LTD.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HIKMA PHARMACEUTICALS PLC
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HRA PHARMA
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HETERO HEALTHCARE LIMITED
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- JUBILANT CADISTA (A SUBSIDIARY OF JUBILANT LIFE SCIENCES LIMITED)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- MERIX PHARMACEUTICAL CORP.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- SQAUREX
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- SUN PHARMACEUTICAL INDUSTRIES LTD.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- VIATRIS INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- WOCKHARDT
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- questionnaire
- related reportS
Lista de Tabela
TABLE 1 EuropeCOLD SORE TREATMENT Market, pipeline analysis
TABLE 2 GENERIC DRUGS USED FOR THE TREATMENT OF HSV (COLD SORES)
TABLE 3 Europe COLD SORE TREATMENT Market, By strain TYPE 2019-2028 (USD Million)
TABLE 4 Europe HERPES SIMPLEX TYPE 1 VIRUS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 5 Europe HERPES SIMPLEX TYPE 2 VIRUS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 6 Europe COLD SORE TREATMENT Market, By THERAPEUTICS 2019-2028 (USD Million)
TABLE 7 Europe ANTIVIRAL AGENTS in COLD SORE TREATMENT Market, By region 2019-2028 (USD Million)
TABLE 8 Europe ANTIVIRAL AGENTS in COLD SORE TREATMENT Market, By therapeutics, 2019-2028 (USD Million)
TABLE 9 Europe ANALGESIC AGENTS in COLD SORE TREATMENT Market, By region, 2019-2028 (USD Million)
TABLE 10 Europe Analgesic AGENTS in COLD SORE TREATMENT Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 11 Europe others in COLD SORE TREATMENT Market, By region, 2019-2028 (USD Million)
TABLE 12 Europe COLD SORE TREATMENT Market, By drug type 2019-2028 (USD Million)
TABLE 13 Europe generics in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 14 Europe generics in COLD SORE TREATMENT Market, By drug type, 2019-2028 (USD Million)
TABLE 15 Europe branded in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 16 Europe branded in COLD SORE TREATMENT Market, By drug type, 2019-2028 (USD Million)
TABLE 17 Europe COLD SORE TREATMENT Market, By dosage type 2019-2028 (USD Million)
TABLE 18 Europe Oral in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 19 Europe Oral segment in COLD SORE TREATMENT Market, By dosage type, 2019-2028 (USD Million)
TABLE 20 Europe TOPICAL segment in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 21 Europe TOPICAL segment in COLD SORE TREATMENT Market, By dosage type, 2019-2028 (USD Million)
TABLE 22 Europe others in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 23 Europe COLD SORE TREATMENT Market, By END USER 2019-2028 (USD Million)
TABLE 24 Europe HOSPITALS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 25 Europe HOspitals in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 26 Europe SPECIALTY CLINICS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 27 Europe OTHERS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 28 Europe COLD SORE TREATMENT Market, By distribution channel 2019-2028 (USD Million)
TABLE 29 Europe Hospitals Pharmacy in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 30 Europe ONLINE Pharmacy in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 31 Europe RETAIL Pharmacy in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)
TABLE 32 EUROPE Cold sore Market, By Country, 2019-2028 (USD Million)
TABLE 33 EUROPE Cold sore Market, By Strain, 2019-2028 (USD Million)
TABLE 34 EUROPE Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 35 EUROPE Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 36 EUROPE Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 37 EUROPE Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 38 EUROPE Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 39 EUROPE Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 40 EUROPE Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 41 EUROPE Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 42 EUROPE Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 43 EUROPE Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 44 EUROPE Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 45 GERMANY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 46 GERMANY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 47 GERMANY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 48 GERMANY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 49 GERMANY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 50 GERMANY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 51 GERMANY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 52 GERMANY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 53 GERMANY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 54 GERMANY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 55 GERMANY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 56 GERMANY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 57 FRANCE Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 58 FRANCE Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 59 FRANCE Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 60 FRANCE Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 61 FRANCE Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 62 FRANCE Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 63 FRANCE Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 64 FRANCE Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 65 FRANCE Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 66 FRANCE Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 67 FRANCE Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 68 FRANCE Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 69 U.K. Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 70 U.K. Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 71 U.K. Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 72 U.K. Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 73 U.K. Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 74 U.K. Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 75 U.K. Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 76 U.K. Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 77 U.K. Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 78 U.K. Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 79 U.K. Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 80 U.K. Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 81 ITALY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 82 ITALY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 83 ITALY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 84 ITALY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 85 ITALY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 86 ITALY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 87 ITALY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 88 ITALY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 89 ITALY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 90 ITALY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 91 ITALY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 92 ITALY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 93 SPAIN Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 94 SPAIN Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 95 SPAIN Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 96 SPAIN Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 97 SPAIN Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 98 SPAIN Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 99 SPAIN Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 100 SPAIN Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 101 SPAIN Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 102 SPAIN Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 103 SPAIN Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 104 SPAIN Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 105 RUSSIA Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 106 RUSSIA Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 107 RUSSIA Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 108 RUSSIA Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 109 RUSSIA Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 110 RUSSIA Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 111 RUSSIA Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 112 RUSSIA Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 113 RUSSIA Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 114 RUSSIA Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 115 RUSSIA Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 116 RUSSIA Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 117 SWITZERLAND Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 118 SWITZERLAND Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 119 SWITZERLAND Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 120 SWITZERLAND Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 121 SWITZERLAND Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 122 SWITZERLAND Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 123 SWITZERLAND Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 124 SWITZERLAND Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 125 SWITZERLAND Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 126 SWITZERLAND Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 127 SWITZERLAND Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 128 SWITZERLAND Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 129 NETHERLAND Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 130 NETHERLAND Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 131 NETHERLAND Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 132 NETHERLAND Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 133 NETHERLAND Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 134 NETHERLAND Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 135 NETHERLAND Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 136 NETHERLAND Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 137 NETHERLAND Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 138 NETHERLAND Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 139 NETHERLAND Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 140 NETHERLAND Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 141 TURKEY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 142 TURKEY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 143 TURKEY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 144 TURKEY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 145 TURKEY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 146 TURKEY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 147 TURKEY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 148 TURKEY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 149 TURKEY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 150 TURKEY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 151 TURKEY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 152 TURKEY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 153 IRELAND Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 154 IRELAND Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 155 IRELAND Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 156 IRELAND Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 157 IRELAND Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 158 IRELAND Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 159 IRELAND Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 160 IRELAND Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 161 IRELAND Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 162 IRELAND Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 163 IRELAND Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 164 IRELAND Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 165 BELGIUM Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 166 BELGIUM Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 167 BELGIUM Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 168 BELGIUM Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 169 BELGIUM Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 170 BELGIUM Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 171 BELGIUM Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 172 BELGIUM Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 173 BELGIUM Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 174 BELGIUM Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 175 BELGIUM Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 176 BELGIUM Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 177 POLAND Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 178 POLAND Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 179 POLAND Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 180 POLAND Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 181 POLAND Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 182 POLAND Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 183 POLAND Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 184 POLAND Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 185 POLAND Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 186 POLAND Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 187 POLAND Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 188 POLAND Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 189 AUSTRIA Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 190 AUSTRIA Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 191 AUSTRIA Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 192 AUSTRIA Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 193 AUSTRIA Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 194 AUSTRIA Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 195 AUSTRIA Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 196 AUSTRIA Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 197 AUSTRIA Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 198 AUSTRIA Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 199 AUSTRIA Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 200 AUSTRIA Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 201 NORWAY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 202 NORWAY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 203 NORWAY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 204 NORWAY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 205 NORWAY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 206 NORWAY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 207 NORWAY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 208 NORWAY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 209 NORWAY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 210 NORWAY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 211 NORWAY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 212 NORWAY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 213 HUNGARY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 214 HUNGARY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 215 HUNGARY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 216 HUNGARY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 217 HUNGARY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 218 HUNGARY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 219 HUNGARY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 220 HUNGARY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 221 HUNGARY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 222 HUNGARY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 223 HUNGARY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 224 HUNGARY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 225 LITHUANIA Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
TABLE 226 LITHUANIA Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 227 LITHUANIA Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 228 LITHUANIA Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)
TABLE 229 LITHUANIA Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 230 LITHUANIA Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 231 LITHUANIA Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)
TABLE 232 LITHUANIA Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 233 LITHUANIA Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 234 LITHUANIA Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)
TABLE 235 LITHUANIA Cold Sore Treatment Market, By End User 2019-2028 (USD Million)
TABLE 236 LITHUANIA Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)
TABLE 237 REST OF EUROPE Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)
Lista de Figura
FIGURE 1 Europe COLD SORE TREATMENT MARKET: SEGMENTATION
FIGURE 2 EUROPE COLD SORE TREATMENT MARKET : DATA TRIANGULATION
FIGURE 3 Europe Cold Sore Treatment Market: DROC ANALYSIS
FIGURE 4 Europe Cold Sore Treatment market: Europe VS REGIONAL MARKET ANALYSIS
FIGURE 5 Europe Cold Sore Treatment Market: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE Cold Sore Treatment MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE Cold Sore Treatment MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE COLD SORE TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE COLD SORE TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE Cold Sore Treatment MARKET: MARKET drug type COVERAGE GRID
FIGURE 11 Europe Cold Sore Treatment market: SEGMENTATION
FIGURE 12 Growing PREVALENCE OF COLD SORE TREATMENT WORLDWIDE, AND PROLIFERATION IN MODES OF TRANSMISSION of herpes simplex virus (hsv), and increasing awareness about sexually transmitted diseases are DRIVing THE Europe Cold Sore treatment market IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 13 HERPES SIMPLEX TYPE 1 VIRUS SEGMENT is expected to account for the largest share of the Europe COLD SORE TREATMENT MARKET in 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE COLD SORE TREATMENT MARKET
FIGURE 15 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, AMONG PERSONS AGED 14-49 YEARS, BY AGE GROUP: IN THE U.S. 2015–2016
FIGURE 16 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, BY RACE AND HISPANIC ORIGIN: U.S. 2015–2016
FIGURE 17 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, BY SEX: IN DIFFERENT COUNTRIES 2015–2016
FIGURE 18 Europe COLD SORE TREATMENT market: BY strain TYPE, 2020
FIGURE 19 Europe COLD SORE TREATMENT market: BY strain TYPE, 2020-2028 (USD Million)
FIGURE 20 Europe COLD SORE TREATMENT market: BY strain TYPE, CAGR (2021-2028)
FIGURE 21 Europe COLD SORE TREATMENT market: BY strain TYPE, LIFELINE CURVE
FIGURE 22 Europe COLD SORE TREATMENT market: BY THERAPEUTICS, 2020
FIGURE 23 Europe COLD SORE TREATMENT market: BY THERAPEUTICS , 2020-2028 (USD Million)
FIGURE 24 Europe COLD SORETREATMENT market: BY THERAPEUTICS, CAGR (2021-2028)
FIGURE 25 Europe COLD SORETREATMENT market: BY THERAPEUTICS, LIFELINE CURVE
FIGURE 26 Europe COLD SORETREATMENT market: BY drug type, 2020
FIGURE 27 Europe COLD SORETREATMENT market: BY drug type 2020-2028 (USD Million)
FIGURE 28 Europe COLD SORETREATMENT market: BY drug type, CAGR (2021-2028)
FIGURE 29 Europe COLD SORETREATMENT market: BY drug type, LIFELINE CURVE
FIGURE 30 Europe COLD SORETREATMENT market: BY dosage type, 2020
FIGURE 31 Europe COLD SORETREATMENT market: BY dosage type 2020-2028 (USD Million)
FIGURE 32 Europe COLD SORETREATMENT market: BY dosage type, CAGR (2021-2028)
FIGURE 33 Europe COLD SORETREATMENT market: BY dosage type, LIFELINE CURVE
FIGURE 34 Europe COLD SORE TREATMENT market: BY END USER, 2020
FIGURE 35 Europe COLD SORE TREATMENT market: BY END USER 2020-2028 (USD Million)
FIGURE 36 Europe COLD SORE TREATMENT market: BY END USER, CAGR (2021-2028)
FIGURE 37 Europe COLD SORE TREATMENT market: BY END USER, LIFELINE CURVE
FIGURE 38 Europe COLD SORE TREATMENT market: BY distribution channel, 2020
FIGURE 39 Europe COLD SORE TREATMENT market: BY distribution channel 2020-2028 (USD Million)
FIGURE 40 Europe COLD SORE TREATMENT market: BY distribution channel, CAGR (2021-2028)
FIGURE 41 Europe COLD SORE TREATMENT market: BY distribution channel, LIFELINE CURVE
FIGURE 42 EUROPE cold sore treatment market: SNAPSHOT (2020)
FIGURE 43 EUROPE cold sore treatment market: BY COUNTRY (2020)
FIGURE 44 EUROPE cold sore treatment market: BY COUNTRY (2021 & 2028)
FIGURE 45 EUROPE cold sore treatment market: BY COUNTRY (2021 & 2028)
FIGURE 46 EUROPE cold sore treatment market: BY strains (2021-2028)
FIGURE 47 Europe cold sore treatment market: company share 2020 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
